| Heart disease and stroke statistics—2010 update: a report from the American Heart Association Writing Group Members, D Lloyd-Jones, RJ Adams, TM Brown, ... Circulation 121 (7), e46-e215, 2010 | 7398 | 2010 |
| Use of carotid ultrasound to identify subclinical vascular disease and evaluate cardiovascular disease risk: a consensus statement from the American Society of Echocardiography … JH Stein, CE Korcarz, RT Hurst, E Lonn, CB Kendall, ER Mohler, ... Journal of the American Society of echocardiography 21 (2), 93-111, 2008 | 2952 | 2008 |
| Rivaroxaban with or without aspirin in stable cardiovascular disease JW Eikelboom, SJ Connolly, J Bosch, GR Dagenais, RG Hart, ... New England Journal of Medicine 377 (14), 1319-1330, 2017 | 2557 | 2017 |
| Homocysteine lowering with folic acid and B vitamins in vascular disease Heart Outcomes Prevention Evaluation (HOPE) 2 Investigators New England Journal of Medicine 354 (15), 1567-1577, 2006 | 2359 | 2006 |
| Effect of rosiglitazone on the frequency of diabetes in patients with impaired glucose tolerance or impaired fasting glucose: a randomised controlled trial DREAM (Diabetes REduction Assessment with ramipril and rosiglitazone ... The Lancet 368 (9541), 1096-1105, 2006 | 2276 | 2006 |
| Apical ballooning syndrome or takotsubo cardiomyopathy: a systematic review M Gianni, F Dentali, AM Grandi, G Sumner, R Hiralal, E Lonn European heart journal 27 (13), 1523-1529, 2006 | 1985 | 2006 |
| Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial AF Hernandez, JB Green, S Janmohamed, RB D'Agostino, CB Granger, ... The Lancet 392 (10157), 1519-1529, 2018 | 1484 | 2018 |
| Effects of long-term vitamin E supplementation on cardiovascular events and cancer: a randomized controlled trial. E Lonn, J Bosch, S Yusuf, P Sheridan, J Pogue, JM Arnold, C Ross, ... Jama 293 (11), 1338-1347, 2005 | 1477 | 2005 |
| Homocyst (e) ine and cardiovascular disease: a critical review of the epidemiologic evidence JW Eikelboom, E Lonn, J Genest Jr, G Hankey, S Yusuf Annals of internal medicine 131 (5), 363-375, 1999 | 1395 | 1999 |
| Differences in risk factors, atherosclerosis, and cardiovascular disease between ethnic groups in Canada: the Study of Health Assessment and Risk in Ethnic groups (SHARE) SS Anand, S Yusuf, V Vuksan, S Devanesen, KK Teo, PA Montague, ... The lancet 356 (9226), 279-284, 2000 | 1369 | 2000 |
| 2012 update of the Canadian Cardiovascular Society guidelines for the diagnosis and treatment of dyslipidemia for the prevention of cardiovascular disease in the adult TJ Anderson, J Grégoire, RA Hegele, P Couture, GBJ Mancini, ... Canadian Journal of Cardiology 29 (2), 151-167, 2013 | 1120 | 2013 |
| 2016 Canadian Cardiovascular Society guidelines for the management of dyslipidemia for the prevention of cardiovascular disease in the adult TJ Anderson, J Grégoire, GJ Pearson, AR Barry, P Couture, M Dawes, ... Canadian Journal of Cardiology 32 (11), 1263-1282, 2016 | 1082 | 2016 |
| Effects of ramipril and vitamin E on atherosclerosis: the study to evaluate carotid ultrasound changes in patients treated with ramipril and vitamin E (SECURE) EM Lonn, S Yusuf, V Dzavik, CI Doris, Q Yi, S Smith, A Moore-Cox, ... Circulation 103 (7), 919-925, 2001 | 1071 | 2001 |
| 2009 Canadian Cardiovascular Society/Canadian guidelines for the diagnosis and treatment of dyslipidemia and prevention of cardiovascular disease in the adult–2009 recommendations J Genest, R McPherson, J Frohlich, T Anderson, N Campbell, ... Canadian Journal of Cardiology 25 (10), 567-579, 2009 | 1067 | 2009 |
| Cholesterol lowering in intermediate-risk persons without cardiovascular disease S Yusuf, J Bosch, G Dagenais, J Zhu, D Xavier, L Liu, P Pais, ... New England Journal of Medicine 374 (21), 2021-2031, 2016 | 1045 | 2016 |
| Rivaroxaban with or without aspirin in patients with stable peripheral or carotid artery disease: an international, randomised, double-blind, placebo-controlled trial SS Anand, J Bosch, JW Eikelboom, SJ Connolly, R Diaz, P Widimsky, ... The Lancet 391 (10117), 219-229, 2018 | 983 | 2018 |
| Common carotid intima-media thickness measurements in cardiovascular risk prediction: a meta-analysis HM Den Ruijter, SAE Peters, TJ Anderson, AR Britton, JM Dekker, ... Jama 308 (8), 796-803, 2012 | 975 | 2012 |
| Blood-pressure lowering in intermediate-risk persons without cardiovascular disease EM Lonn, J Bosch, P López-Jaramillo, J Zhu, L Liu, P Pais, R Diaz, ... New England Journal of Medicine 374 (21), 2009-2020, 2016 | 817 | 2016 |
| Reduction of cardiovascular risk by regression of electrocardiographic markers of left ventricular hypertrophy by the angiotensin-converting enzyme inhibitor ramipril J Mathew, P Sleight, E Lonn, D Johnstone, J Pogue, Q Yi, J Bosch, ... Circulation 104 (14), 1615-1621, 2001 | 755 | 2001 |
| Emerging role of angiotensin-converting enzyme inhibitors in cardiac and vascular protection. EM Lonn, S Yusuf, P Jha, TJ Montague, KK Teo, CR Benedict, B Pitt Circulation 90 (4), 2056-2069, 1994 | 754 | 1994 |
Salim YusufPopulation Health Research Institute, McMaster University and Hamilton Health SciencesEmail verificata su mcmaster.ca